CVS stock fundamentals - financials as reported
Financials As Reported
- accession Number 0000064803-23-000016
- accounts Receivable Net Current 28,331,000,000
- accumulated Other Comprehensive Income Loss Net Of Tax --875,000,000
- amendment Flag false
- assets 239,330,000,000
- assets Current 68,706,000,000
- cash And Cash Equivalents At Carrying Value 14,618,000,000
- cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 14,955,000,000
- cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 1,650,000,000
- cik 64,803
- city Area Code (401)
- common Stock Dividends Per Share Declared 0.605
- common Stock Par Or Stated Value Per Share 0.01
- common Stock Shares Authorized 3,200,000,000
- common Stock Shares Issued 1,759,000,000
- common Stock Shares Outstanding 1,279,000,000
- common Stocks Including Additional Paid In Capital 48,306,000,000
- comprehensive Income Net Of Tax 2,525,000,000
- contract With Customer Liability Current 136,000,000
- cost Of Goods And Services Sold 51,455,000,000
- current Fiscal Year End Date --12-31
- date Filed 2023-05-03
- depreciation Depletion And Amortization 1,001,000,000
- document Fiscal Period Focus Q1
- document Fiscal Year Focus 2,023
- document Period End Date 2023-03-31
- document Transition Report false
- document Type 10-Q
- earnings Per Share Basic 1.66
- earnings Per Share Diluted 1.65
- entity Address Address Line 1 One CVS Drive,
- entity Address City Or Town Woonsocket,
- entity Address Postal Zip Code 2,895
- entity Address State Or Province RI
- entity Central Index Key 64,803
- entity Current Reporting Status Yes
- entity Emerging Growth Company false
- entity File Number 001-01011
- entity Filer Category Large Accelerated Filer
- entity Incorporation State Country Code DE
- entity Interactive Data Current Yes
- entity Name CVS HEALTH Corp
- entity Registrant Name CVS HEALTH CORPORATION
- entity Shell Company false
- entity Small Business false
- entity Tax Identification Number 05-0494040
- finance Lease Liability 1,483,000,000
- income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 2,879,000,000
- income Taxes Paid Net 75,000,000
- income Tax Expense Benefit 737,000,000
- increase Decrease In Accounts Payable --1,203,000,000
- increase Decrease In Accounts Receivable 751,000,000
- increase Decrease In Inventories --828,000,000
- increase Decrease In Other Operating Assets 1,255,000,000
- increase Decrease In Other Operating Liabilities 2,036,000,000
- interest Expense 589,000,000
- interest Paid Net 773,000,000
- inventory Net 18,263,000,000
- investment Income Interest And Dividend 449,000,000
- irs Number 50,494,040
- liabilities 167,750,000,000
- liabilities And Stockholders Equity 239,330,000,000
- liabilities Current 75,054,000,000
- local Phone Number 765-1500
- net Cash Provided By Used In Financing Activities 2,726,000,000
- net Cash Provided By Used In Investing Activities --8,514,000,000
- net Cash Provided By Used In Operating Activities 7,438,000,000
- net Income Loss 2,136,000,000
- operating Income Loss 3,446,000,000
- operating Lease Liability Current 1,679,000,000
- operating Lease Liability Noncurrent 16,571,000,000
- operating Lease Right Of Use Asset 17,660,000,000
- other Assets Current 3,767,000,000
- other Assets Noncurrent 4,824,000,000
- other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax --1,000,000
- other Liabilities Noncurrent 6,671,000,000
- other Nonoperating Income Expense 22,000,000
- payments For Proceeds From Other Investing Activities --31,000,000
- payments For Repurchase Of Common Stock 2,018,000,000
- payments Of Dividends 779,000,000
- payments Related To Tax Withholding For Share Based Compensation 34,000,000
- payments To Acquire Businesses Net Of Cash Acquired 7,094,000,000
- payments To Acquire Property Plant And Equipment 984,000,000
- period End 1,680,220,800,000
- period Start 1,672,531,200,000
- proceeds From Issuance Of Long Term Debt 5,951,000,000
- proceeds From Payments For Other Financing Activities --128,000,000
- proceeds From Sale Of Available For Sale Securities Debt 1,341,000,000
- property Plant And Equipment Net 12,872,000,000
- repayments Of Long Term Debt 362,000,000
- report Link https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/cvs-20230331_htm.xml
- retained Earnings Accumulated Deficit 57,753,000,000
- share Based Compensation 103,000,000
- stockholders Equity 71,382,000,000
- trading Symbol CVS
- update 1970-01-01
- weighted Average Number Of Diluted Shares Outstanding 1,291,000,000
- weighted Average Number Of Shares Outstanding Basic 1,283,000,000
- id REPORTED_FINANCIALS
- key CVS
- subkey 10-Q
- date 2023-05-03
- updated 2023-05-04
Related News
Nvidia (NASDAQ: NVDA) Stock: AI and Data Center Growth Make It a Must-Buy Despite 140% YTD Rally
TradingNEWS Archive
19.09.24
Datadog (NASDAQ: DDOG): AI Expansion Powers Revenue Growth, But Is the Stock Still a Buy?
TradingNEWS Archive
18.09.24
JPMorgan Chase (NYSE: JPM) Stock: A Smart Buy After Recent Pullback?
TradingNEWS Archive
17.09.24
IBM (NASDAQ: IBM) Takes Off as AI and Cloud Strategy Hit Full Speed
TradingNEWS Archive
16.09.24
Dell 70% Upside Potential (NASDAQ: DELL) Positioned for Explosive Growth Amid AI Surge and S&P 500 Inclusion
TradingNEWS Archive
13.09.24
Microsoft (NASDAQ: MSFT): Stock Price Soars Amid AI Expansion and Cloud Leadership
TradingNEWS Archive
12.09.24